These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17560098

  • 1. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
    Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N.
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
    [Abstract] [Full Text] [Related]

  • 2. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
    Loria P, Lonardo A, Targher G.
    Clin Sci (Lond); 2008 Jul; 115(1):1-12. PubMed ID: 19016656
    [Abstract] [Full Text] [Related]

  • 3. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia-Pacific Working Party for NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [Abstract] [Full Text] [Related]

  • 4. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM, Ostapowicz G, Weltman MD.
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [Abstract] [Full Text] [Related]

  • 5. The role of non-alcoholic fatty liver disease in cardiovascular disease.
    Perseghin G.
    Dig Dis; 2010 Feb; 28(1):210-3. PubMed ID: 20460913
    [Abstract] [Full Text] [Related]

  • 6. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA, Kuipers F, Stolk RP.
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [Abstract] [Full Text] [Related]

  • 7. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
    Hurjui DM, Niţă O, Graur LI, Mihalache L, Popescu DS, Graur M.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jul; 116(2):425-31. PubMed ID: 23077931
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.
    Targher G.
    Diabet Med; 2007 Jan; 24(1):1-6. PubMed ID: 17227317
    [Abstract] [Full Text] [Related]

  • 9. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 10. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG.
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [Abstract] [Full Text] [Related]

  • 11. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 12. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D, Pipalia D, Chawla M, Patel R, Maniar S, Narayani, Juneja A.
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [Abstract] [Full Text] [Related]

  • 13. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, Rudilosso A, Ballestri S, Carulli N.
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [Abstract] [Full Text] [Related]

  • 14. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM, McCullough AJ.
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.
    Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS.
    Diabetes Res Clin Pract; 2009 Apr; 84(1):84-91. PubMed ID: 19168251
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G.
    Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
    [Abstract] [Full Text] [Related]

  • 17. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 18. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK.
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
    Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S.
    Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
    [Abstract] [Full Text] [Related]

  • 20. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL, de Silva HJ, Leung NW, Lim SG, Farrell GC, Asia-Pacific Working Party on NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.